Long-term calcium and vitamin D supplementation does not impact all-cause mortality
1. In this randomized controlled trial, long-term calcium and vitamin D (CaD) supplementation was associated with lower cancer mortality and ...
Tag: menopause
Bayer AG: Elinzanetant Shows Promise In Treating Menopause-Associated Vasomotor Symptoms In Phase 3 Clinical Trials
Elinzanetant reduced the frequency and severity of menopause-associated vasomotor symptoms in two phase 3 clinical trials. Elinzanetant was safe and ...
The Scan by 2 Minute Medicine®: Vampire Facials: HIV in Pursuit of Beauty, Fentanyl Awareness Day, Marijuana Reclassification: Cannabis Restrictions to Ease?, Menopause Meds: A Safe Passage
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
Severe premenstrual disorder may increase risk of early onset perimenopausal symptoms
1. This prospective study found that women with severe premenstrual disorders (PMDs) were at increased risk for early onset of ...
The 2 Minute Medicine Podcast Episode 18
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...
The Scan by 2 Minute Medicine®: Veozah for Hot Flashes, Affordable Care Act Mandate for Preventive Care, Pride Month, and RSV Drug for Infants
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
Benign hysterectomy with ovarian removal is not associated with clear survival benefit
1. In this population-based cohort study, compared to women without bilateral salpingo-oophorectomy (BSO), women with BSO had a higher overall ...
Yogurt intake may be associated with a lower risk of obesity during the menopausal transition
1. In this prospective cohort study, higher yogurt intake was associated with lower weight gain and obesity risk in women ...
Wellness Check: Nutrition
Yogurt intake may be associated with a lower risk of obesity during the menopausal transition 1. In this prospective cohort ...
Fezolinetant significantly reduces vasomotor symptoms in post-menopausal women
1. Fezolinetant 30 mg and 45 mg significantly reduced the frequency and severity of vasomotor symptoms compared to placebo. 2. ...